Part 1 obgyn notes Sri Lanka
    MD obgyn part 1 notes srilanka
    /
    pathology
    /
    3.Inflammation & repair
    /
    inflammation & repair recall

    inflammation & repair recall

    Owner
    U
    Untitled
    Verification
    Tags

    🧠 SARR β€” SEGMENT 1

    TOPIC: OVERVIEW OF INFLAMMATION β€” Definition, Purpose & Core Logic

    ❓ Q1. What is inflammation?

    A:

    Inflammation is a protective response of vascularized tissues to infection and tissue injury, designed to deliver host defense cells and plasma proteins from the blood to the site of damage.

    ❓ Q2. Why is inflammation considered a protective response?

    A:

    Because it enables the body to:

    • Eliminate microbes and toxins
    • Remove necrotic (dead) tissue
    • Initiate tissue repair

    Without inflammation, survival is not possible.

    ❓ Q3. Why is inflammation often misunderstood as harmful?

    A:

    Because inflammation can cause:

    • Pain
    • Swelling
    • Tissue damage

    However, this damage is a by-product of defense, not the primary goal.

    ❓ Q4. What would happen if inflammation did not exist?

    A:

    • Infections would persist unchecked
    • Wounds would fail to heal
    • Injured tissues would remain chronically damaged
    • Death would occur even from minor injuries

    ❓ Q5. What does inflammation aim to eliminate? (Two targets)

    A:

    1. The primary cause of injury
      • Microbes
      • Toxins
    2. The consequences of injury
      • Necrotic cells
      • Damaged tissue

    ➑️ Inflammation removes both the insult AND its aftermath.

    ❓ Q6. Which components carry out inflammatory defense?

    A:

    • Phagocytic leukocytes (neutrophils, macrophages)
    • Antibodies
    • Complement proteins

    ❓ Q7. Why are most inflammatory components kept inactive in blood?

    A:

    To:

    • Prevent unnecessary damage to normal tissues
    • Allow rapid, controlled activation only when needed

    This is a key safety mechanism.

    ❓ Q8. Are all immune cells circulating in blood?

    A:

    No. Some immune cells:

    • Reside permanently in tissues
    • Act as sentinels
    • Constantly monitor for:
      • Microbes
      • Tissue injury

    ❓ Q9. What is the core function of the inflammatory process?

    A:

    To:

    • Deliver leukocytes and plasma proteins to sites of injury
    • Activate them locally so they can:
      • Destroy harmful agents
      • Clear dead tissue

    ➑️ Activation is localized, not systemic, under normal conditions.

    ❓ Q10. Why must inflammatory activation remain localized?

    A:

    Because systemic activation would:

    • Damage healthy tissues
    • Lead to life-threatening systemic inflammation

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    Inflammation is a protective, localized response of vascularized tissues that delivers and activates leukocytes and plasma proteins to eliminate injurious agents and necrotic tissue and initiate repair.

    🧠 CLINICAL CORRELATION (High-Yield)

    • Absent or defective inflammation β†’ recurrent infections, poor wound healing
    • Excessive or misdirected inflammation β†’ autoimmune disease, tissue destruction

    🧠 SARR β€” SEGMENT 2

    TOPIC: WHAT INFLAMMATION ELIMINATES & THE DEFENSIVE COMPONENTS

    ❓ Q1. What are the TWO broad categories of things inflammation eliminates?

    A:

    1. Injurious agents
    2. Damaged host tissues

    Inflammation always targets both the cause and the consequence of injury.

    ❓ Q2. What are considered β€œinjurious agents”?

    A:

    • Infectious organisms
      • Bacteria
      • Viruses
      • Fungi
      • Parasites
    • Toxins
      • Exogenous (bacterial toxins, chemicals)
      • Endogenous (necrotic cell products)

    ❓ Q3. What are considered β€œdamaged host tissues”?

    A:

    • Necrotic cells
    • Dead tissue fragments
    • Damaged extracellular matrix
    • Cellular debris generated by:
      • Trauma
      • Ischemia
      • Physical or chemical injury

    ❓ Q4. Why must necrotic tissue be removed?

    A:

    Because necrotic tissue:

    • Acts as a nidus for infection
    • Releases DAMPs (damage-associated molecular patterns)
    • Perpetuates inflammation if not cleared
    • Prevents effective tissue repair

    ❓ Q5. Which THREE major systems mediate inflammatory defense?

    A:

    1. Leukocytes
    2. Plasma proteins
    3. Resident tissue cells

    ❓ Q6. Which leukocytes are most important in inflammation?

    A:

    • Neutrophils
      • First responders
      • Dominant in acute inflammation
    • Macrophages
      • Derived from monocytes
      • Key cells in both acute and chronic inflammation

    ❓ Q7. What are the main functions of leukocytes in inflammation?

    A:

    • Phagocytosis of microbes and debris
    • Killing of pathogens
      • Reactive oxygen species
      • Lysosomal enzymes
    • Cytokine production
      • Amplifies and regulates inflammation

    ❓ Q8. Which plasma proteins participate in inflammation?

    A:

    • Antibodies
    • Complement system
    • Coagulation and kinin systems (supportive roles)

    ❓ Q9. What is the role of complement in inflammation?

    A:

    Complement contributes by:

    • Opsonization (C3b)
    • Leukocyte recruitment (C5a)
    • Direct microbial killing (MAC)

    ❓ Q10. What role do resident tissue cells play?

    A:

    Resident cells act as sentinels:

    • Macrophages
    • Dendritic cells
    • Mast cells
    • Endothelial cells

    They:

    • Detect injury or microbes
    • Release mediators
    • Initiate inflammation before leukocytes arrive

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    Inflammation eliminates injurious agents and necrotic tissue using leukocytes, plasma proteins, and resident sentinel cells to clear damage and enable repair.

    🧠 CLINICAL CORRELATION (High-Yield)

    • Failure to clear necrotic tissue β†’ chronic inflammation
    • Excess leukocyte activation β†’ collateral tissue injury
    • Complement deficiency β†’ recurrent infections

    🧠 SARR β€” SEGMENT 3

    TOPIC: ACUTE vs CHRONIC INFLAMMATION β€” CORE DIFFERENCES, LOGIC & EXAM TRAPS

    ❓ Q1. How is inflammation broadly classified?

    A:

    Inflammation is classified into:

    1. Acute inflammation
    2. Chronic inflammation

    The distinction is based on time course, cellular profile, and outcome.

    ❓ Q2. What defines ACUTE inflammation?

    A:

    Acute inflammation is a rapid, short-duration response characterized by:

    • Immediate onset (minutes to hours)
    • Short duration (hours to days)
    • Dominance of neutrophils
    • Prominent vascular changes

    ❓ Q3. What are the TWO major components of acute inflammation?

    A:

    1. Vascular changes
      • Vasodilation
      • Increased permeability
    2. Cellular events
      • Neutrophil recruitment
      • Phagocytosis

    ❓ Q4. What are the main causes of acute inflammation?

    A:

    • Infections (especially bacterial)
    • Tissue necrosis (ischemia, trauma)
    • Foreign bodies
    • Immune reactions (hypersensitivity)

    ❓ Q5. What are the possible outcomes of acute inflammation? (EXAM FAVORITE)

    A:

    1. Complete resolution
      • Restoration of normal tissue
    2. Healing by fibrosis (scarring)
      • When damage is extensive
    3. Progression to chronic inflammation

    ❓ Q6. What defines CHRONIC inflammation?

    A:

    Chronic inflammation is a prolonged inflammatory response characterized by:

    • Long duration (weeks to years)
    • Simultaneous inflammation, tissue destruction, and repair
    • Dominance of mononuclear cells

    ❓ Q7. Which cells dominate chronic inflammation?

    A:

    • Macrophages (central cell)
    • Lymphocytes
    • Plasma cells

    ⚠️ Neutrophils are not dominant in chronic inflammation.

    ❓ Q8. What are the THREE major features of chronic inflammation?

    A:

    1. Persistent inflammatory cell infiltrate
    2. Ongoing tissue destruction
    3. Attempts at healing
      • Angiogenesis
      • Fibrosis

    ❓ Q9. What causes chronic inflammation?

    A:

    • Persistent infections
      • Mycobacterium tuberculosis
      • Fungi
    • Autoimmune diseases
      • Rheumatoid arthritis
    • Prolonged exposure to toxic agents
      • Silica
      • Lipids (atherosclerosis)

    ❓ Q10. What is the KEY LOGIC difference between acute and chronic inflammation?

    A:

    • Acute inflammation aims at rapid elimination and resolution
    • Chronic inflammation reflects failure to eliminate the cause

    πŸ”‘ EXAM LOCK β€” TABLE MEMORY (IN WORDS)

    • Acute β†’ fast, neutrophils, edema, resolution or scar
    • Chronic β†’ slow, macrophages + lymphocytes, tissue destruction + fibrosis

    🧠 CLINICAL CORRELATION (High-Yield)

    • TB, sarcoidosis β†’ chronic inflammation
    • Acute appendicitis β†’ acute inflammation
    • Rheumatoid arthritis β†’ chronic inflammatory disease
    • Recurrent acute episodes β†’ may evolve into chronic inflammation

    🧠 SARR β€” SEGMENT 4

    TOPIC: VASCULAR CHANGES IN ACUTE INFLAMMATION β€” MECHANISM, LOGIC & EXAM TRAPS

    ❓ Q1. What is the FIRST vascular event in acute inflammation?

    A:

    A brief, transient vasoconstriction of arterioles.

    • Lasts seconds
    • Has no major clinical significance
    • Often ignored in exams

    ❓ Q2. What is the MOST IMPORTANT vascular change in acute inflammation?

    A:

    Vasodilation of arterioles and capillary beds.

    This is the key event.

    ❓ Q3. What causes vasodilation in acute inflammation?

    A:

    Primarily mediated by:

    • Histamine
    • Nitric oxide (NO)

    Released from:

    • Mast cells
    • Endothelial cells

    ❓ Q4. What are the CONSEQUENCES of vasodilation?

    A:

    • ↑ Blood flow to the affected area (hyperemia)
    • Produces:
      • Redness (rubor)
      • Heat (calor)

    ❓ Q5. What is increased vascular permeability?

    A:

    Leakage of protein-rich plasma fluid from the intravascular space into the extravascular tissue.

    This fluid is called exudate.

    ❓ Q6. Why is increased permeability important?

    A:

    Because it allows:

    • Antibodies
    • Complement proteins
    • Clotting factors

    to reach the site of injury.

    ❓ Q7. What are the MAIN MECHANISMS of increased vascular permeability? (EXAM CORE)

    A:

    1. Endothelial cell contraction
      • Most common mechanism
      • Mediated by histamine, bradykinin, leukotrienes
      • Occurs in post-capillary venules
      • Rapid and reversible
    2. Direct endothelial injury
      • Burns, toxins, severe infections
      • Causes sustained leakage
    3. Leukocyte-mediated endothelial injury
      • During adhesion and migration
      • Seen in severe inflammation

    ❓ Q8. What is the difference between EXUDATE and TRANSUDATE? (FREQUENT MCQ)

    A:

    • Exudate
      • High protein
      • High cell content
      • Seen in inflammation
    • Transudate
      • Low protein
      • Few cells
      • Due to ↑ hydrostatic pressure or ↓ oncotic pressure
      • Not inflammatory

    ❓ Q9. How does fluid loss affect blood flow?

    A:

    • Plasma loss β†’ ↑ blood viscosity
    • Slowing of blood flow β†’ stasis
    • Red cells become more concentrated

    ❓ Q10. Why is stasis important in inflammation?

    A:

    Stasis allows:

    • Leukocytes to move from the center of blood flow to the vessel periphery
    • This sets up leukocyte margination

    ➑️ This is essential for leukocyte recruitment.

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    Acute inflammation causes vasodilation and increased vascular permeability, producing exudate, hyperemia, stasis, and setting the stage for leukocyte margination and migration.

    🧠 CLINICAL CORRELATION (High-Yield)

    • Edema = fluid + protein leakage due to permeability
    • Burns β†’ direct endothelial injury β†’ severe edema
    • Hypoalbuminemia edema β†’ transudate, not inflammation

    SARR β€” SEGMENT 5

    TOPIC: LEUKOCYTE RECRUITMENT β€” MARGINATION, ROLLING, ADHESION & TRANSMIGRATION

    ❓ Q1. Why must leukocytes leave the bloodstream during inflammation?

    A:

    Because microbes and necrotic tissue are located in the extravascular tissues, not inside blood vessels.

    ❓ Q2. Where does leukocyte recruitment mainly occur?

    A:

    In post-capillary venules, because:

    • Blood flow is slow
    • Endothelial cells respond strongly to inflammatory mediators

    ❓ Q3. What are the STEPS of leukocyte recruitment? (EXAM SEQUENCE)

    A:

    1. Margination
    2. Rolling
    3. Firm adhesion
    4. Transmigration (diapedesis)
    5. Chemotaxis toward the site of injury

    ❓ Q4. What is margination?

    A:

    Movement of leukocytes from the central axial flow of blood to the peripheral endothelial surface.

    Occurs due to:

    • Stasis caused by plasma leakage

    ❓ Q5. What mediates leukocyte rolling?

    A:

    Selectins

    • E-selectin (endothelial)
    • P-selectin (endothelial & platelets)
    • L-selectin (leukocyte)

    These cause weak, transient adhesions, producing a β€œrolling” motion.

    ❓ Q6. What induces selectin expression on endothelium?

    A:

    • TNF
    • IL-1

    Released from:

    • Macrophages
    • Mast cells

    ❓ Q7. What mediates firm adhesion of leukocytes?

    A:

    Integrins on leukocytes binding to:

    • ICAM-1
    • VCAM-1 on endothelium

    Integrins are activated by chemokines.

    ❓ Q8. What is transmigration (diapedesis)?

    A:

    Passage of leukocytes through endothelial junctions into tissues.

    Mediated by:

    • PECAM-1 (CD31)

    Occurs mainly in:

    • Post-capillary venules

    ❓ Q9. What is chemotaxis?

    A:

    Directed movement of leukocytes toward higher concentrations of chemical attractants.

    ❓ Q10. What are the MAJOR chemotactic factors? (EXAM FAVORITE)

    A:

    • Bacterial products
    • C5a
    • LTB4
    • IL-8

    πŸ”‘ EXAM LOCK β€” STEPWISE MEMORY LINE

    Stasis β†’ Margination β†’ Selectin-mediated rolling β†’ Integrin-mediated adhesion β†’ PECAM-1 transmigration β†’ Chemotaxis

    🧠 CLINICAL CORRELATION (High-Yield)

    • Leukocyte adhesion deficiency β†’ recurrent infections, no pus, delayed wound healing
    • Anti-TNF drugs reduce leukocyte recruitment
    • Steroids inhibit adhesion molecule expression

    🧠 SARR β€” SEGMENT 6

    TOPIC: PHAGOCYTOSIS & LEUKOCYTE-MEDIATED TISSUE INJURY

    ❓ Q1. What is phagocytosis?

    A:

    Phagocytosis is the process by which leukocytes recognize, engulf, and destroy microbes and necrotic debris.

    It is the central effector function of acute inflammation.

    ❓ Q2. Which cells are the main phagocytes?

    A:

    • Neutrophils β†’ early, short-lived
    • Macrophages β†’ later, long-lived, dominant in chronic inflammation

    ❓ Q3. What are the STEPS of phagocytosis? (EXAM SEQUENCE)

    A:

    1. Recognition & attachment
    2. Engulfment
    3. Killing & degradation

    ❓ Q4. How do leukocytes recognize microbes?

    A:

    Through:

    • Opsonins coating the microbe

    Main opsonins:

    • IgG - FcR
    • C3b - CR
    • Collectins - Lectin R

    These bind to specific receptors on phagocytes.

    ❓ Q5. What happens during engulfment?

    A:

    • The phagocyte membrane surrounds the particle
    • Forms a phagosome
    • Phagosome fuses with lysosome β†’ phagolysosome

    ❓ Q6. How are microbes killed inside phagolysosomes?

    A:

    By two mechanisms:

    1️⃣ Reactive oxygen species (ROS)

    • Generated by NADPH oxidase
    • Produces superoxide β†’ hydrogen peroxide
    • Myeloperoxidase (MPO) β†’ hypochlorous acid (HOCl)

    2️⃣ Nitric oxide (NO)

    • Produced by inducible nitric oxide synthase (iNOS)
    • Forms reactive nitrogen species, oNoo-

    ❓ Q7. What non-oxygen-dependent mechanisms kill microbes?

    A:

    • Lysosomal enzymes
    • Defensins
    • Lactoferrin
    • Proteases

    ❓ Q8. What is leukocyte-mediated tissue injury?

    A:

    Damage to host tissues caused by:

    • ROS
    • Proteases
    • Enzymes released from activated leukocytes

    This damage is collateral, not intentional.

    ❓ Q9. When does leukocyte-mediated tissue injury occur?

    A:

    • During severe inflammation
    • When inflammation is prolonged
    • In autoimmune and hypersensitivity reactions
    • When phagocytes release contents extracellularly

    ❓ Q10. How does the body limit leukocyte-mediated injury?

    A:

    • Antioxidants (e.g. catalase, superoxide dismutase)
    • Protease inhibitors (e.g. Ξ±1-antitrypsin)
    • Rapid clearance of activated leukocytes

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    Phagocytosis involves opsonin-mediated recognition, phagolysosome formation, and microbial killing by ROS and NO, with collateral host tissue injury occurring from uncontrolled leukocyte activation.

    🧠 CLINICAL CORRELATION (High-Yield)

    • Chronic granulomatous disease β†’ defective NADPH oxidase β†’ recurrent infections
    • Ξ±1-antitrypsin deficiency β†’ unchecked protease activity β†’ tissue destruction
    • ARDS β†’ neutrophil-mediated lung injury

    🧠 SARR β€” SEGMENT 7

    TOPIC: TERMINATION OF ACUTE INFLAMMATION & ANTI-INFLAMMATORY MECHANISMS

    ❓ Q1. Why must inflammation be actively terminated?

    A:

    Because continued inflammation would:

    • Cause progressive tissue damage
    • Delay or prevent healing
    • Lead to chronic inflammation

    ➑️ Resolution is an active, regulated process, not passive fading.

    ❓ Q2. When does termination of acute inflammation begin?

    A:

    As soon as the injurious stimulus is eliminated and neutrophil influx slows.

    Resolution overlaps with late acute inflammation.

    ❓ Q3. What are the MAIN MECHANISMS that terminate acute inflammation? (EXAM CORE)

    A:

    1. Removal of the inciting stimulus
    2. Short half-life of inflammatory mediators
    3. Neutrophil apoptosis
    4. Switch to anti-inflammatory mediators
    5. Macrophage-mediated cleanup

    ❓ Q4. Why do inflammatory mediators have short half-lives?

    A:

    • Cytokines, prostaglandins, leukotrienes are:
      • Rapidly degraded
      • Produced only when stimulated

    ➑️ Once the stimulus stops, mediator levels fall quickly.

    ❓ Q5. What happens to neutrophils during resolution?

    A:

    • Neutrophils undergo apoptosis
    • Apoptotic neutrophils are:
      • Non-inflammatory
      • Rapidly phagocytosed by macrophages

    ❓ Q6. What is the role of macrophages in resolution?

    A:

    Macrophages:

    • Clear apoptotic neutrophils
    • Remove debris and necrotic tissue
    • Switch phenotype from:
      • Pro-inflammatory (M1) β†’ anti-inflammatory / reparative (M2)

    ❓ Q7. Which mediators actively suppress inflammation? (EXAM FAVORITE)

    A:

    • IL-10
    • TGF-Ξ²
    • Lipoxins
    • Resolvins
    • Protectins

    These:

    • Inhibit leukocyte recruitment
    • Suppress cytokine production
    • Promote tissue repair

    ❓ Q8. What is mediator β€œclass switching”?

    A:

    A shift from:

    • Pro-inflammatory mediators
      • Prostaglandins
      • Leukotrienes
      • to:

    • Anti-inflammatory mediators
      • Lipoxins
      • Resolvins

    This switch is essential for resolution.

    ❓ Q9. What are the POSSIBLE OUTCOMES after acute inflammation resolves?

    A:

    1. Complete resolution
      • Normal tissue restored
    2. Healing by fibrosis
      • If tissue damage is extensive
    3. Progression to chronic inflammation
      • If stimulus persists

    ❓ Q10. What causes failure of resolution?

    A:

    • Persistent infection
    • Autoimmune reactions
    • Continued exposure to toxins
    • Recurrent tissue injury

    ➑️ Leads to chronic inflammation.

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    Termination of acute inflammation is an active process involving neutrophil apoptosis, macrophage cleanup, short-lived mediators, and a switch to anti-inflammatory cytokines such as IL-10 and TGF-Ξ².

    🧠 CLINICAL CORRELATION (High-Yield)

    • Steroids enhance resolution by inhibiting pro-inflammatory gene transcription
    • Failure of resolution β†’ chronic inflammatory diseases
    • Excess TGF-Ξ² β†’ fibrosis and organ scarring

    🧠 SARR β€” SEGMENT 8

    TOPIC: SYSTEMIC EFFECTS OF INFLAMMATION β€” ACUTE-PHASE RESPONSE & FEVER

    ❓ Q1. What are the systemic effects of inflammation called?

    A:

    They are collectively called the acute-phase response.

    This represents whole-body reactions to local inflammation.

    ❓ Q2. What triggers the acute-phase response?

    A:

    Pro-inflammatory cytokines released into the circulation:

    • IL-1
    • TNF
    • IL-6 (most important for liver effects)

    ❓ Q3. What are the MAJOR components of the acute-phase response? (EXAM CORE)

    A:

    1. Fever
    2. Acute-phase proteins
    3. Leukocytosis
    4. Constitutional symptoms
      • Malaise
      • Anorexia
      • Somnolence

    πŸ”₯ FEVER

    ❓ Q4. How does fever develop in inflammation?

    A:

    • IL-1 and TNF stimulate production of prostaglandin E2 (PGE2)
    • PGE2 acts on the hypothalamus
    • Raises the thermoregulatory set point
    • Body generates heat β†’ fever

    ❓ Q5. Why is fever beneficial?

    A:

    Fever:

    • Inhibits growth of some microbes
    • Enhances immune cell function
    • Improves host defense efficiency

    ❓ Q6. Why do antipyretics reduce fever?

    A:

    Because drugs like paracetamol and NSAIDs:

    • Inhibit cyclooxygenase
    • ↓ PGE2 synthesis
    • Reset hypothalamic set point to normal

    πŸ§ͺ ACUTE-PHASE PROTEINS

    ❓ Q7. What are acute-phase proteins?

    A:

    Plasma proteins whose levels increase or decrease in response to inflammation.

    Synthesized mainly by the liver under IL-6 stimulation.

    ❓ Q8. Which are the IMPORTANT positive acute-phase proteins? (EXAM FAVORITE)

    A:

    • C-reactive protein (CRP)
    • Fibrinogen
    • Serum amyloid A (SAA)
    • Haptoglobin
    • Ξ±1-antitrypsin
    • Ferritin
    • Procalcitonin
    • Ceruloplasmin
    • Complement proteins

    NEGATIVE acute phase proteins

    • Albumin
    • Transferrin

    ❓ Q9. What are the functions of CRP?

    A:

    CRP:

    • Binds microbes and dead cells
    • Acts as an opsonin
    • Activates complement

    ➑️ Marker of acute inflammation.

    ❓ Q10. Why does ESR rise in inflammation?

    A:

    Because:

    • ↑ Fibrinogen β†’ RBCs stack (rouleaux formation)
    • RBCs settle faster
    • ESR increases

    🩸 LEUKOCYTOSIS

    ❓ Q11. What is leukocytosis?

    A:

    Increase in white blood cell count in response to inflammation.

    ❓ Q12. What type of leukocytosis is seen in different conditions?

    A:

    • Neutrophilia β†’ bacterial infections
    • Lymphocytosis β†’ viral infections
    • Eosinophilia β†’ parasitic infections, allergies

    ❓ Q13. What is a β€œleft shift”?

    A:

    Presence of immature neutrophils (bands) in blood.

    Indicates acute bacterial infection.

    ⚠️ SEVERE SYSTEMIC INFLAMMATION

    ❓ Q14. What happens in excessive systemic inflammation?

    A:

    High levels of TNF and IL-1 can cause:

    • Septic shock
    • Hypotension
    • DIC
    • Metabolic abnormalities
    • Multi-organ failure

    ❓ Q15. What is the key danger of uncontrolled systemic inflammation?

    A:

    Loss of localized control β†’ life-threatening systemic effects.

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    The acute-phase response is driven by IL-1, TNF, and IL-6 and includes fever (via PGE2), acute-phase protein synthesis, leukocytosis, and constitutional symptoms.

    🧠 CLINICAL CORRELATION (High-Yield)

    • CRP rises faster and normalizes quicker than ESR
    • Persistently high SAA β†’ secondary amyloidosis
    • Anti-TNF therapy reduces systemic inflammatory manifestations

    🧠 SARR β€” SEGMENT 9

    TOPIC: CHRONIC INFLAMMATION β€” MACROPHAGE ACTIVATION, CYTOKINES & TISSUE DAMAGE

    ❓ Q1. What is the DEFINING feature of chronic inflammation?

    A:

    Chronic inflammation is defined by persistent immune activation with:

    • Ongoing inflammation
    • Progressive tissue destruction
    • Simultaneous repair (fibrosis + angiogenesis)

    All three occur at the same time.

    ❓ Q2. Which cell is the CENTRAL regulator of chronic inflammation?

    A:

    The macrophage.

    ➑️ It is the key effector, regulator, and amplifier of chronic inflammation.

    ❓ Q3. Where do macrophages in chronic inflammation come from?

    A:

    From:

    • Circulating monocytes recruited from blood
    • Resident tissue macrophages activated locally

    Both contribute continuously.

    ❓ Q4. What keeps macrophages activated in chronic inflammation?

    A:

    Persistent stimuli:

    • Microbial products (e.g. TB)
    • Immune complexes
    • Autoimmune reactions
    • Foreign materials
    • Cytokines from T lymphocytes

    ❓ Q5. What are the TWO major activation states of macrophages? (EXAM CORE)

    A:

    1. Classically activated macrophages (M1)
    2. Alternatively activated macrophages (M2)

    ❓ Q6. What activates M1 macrophages?

    A:

    • IFN-Ξ³ from Th1 cells
    • Microbial products (via TLRs)

    ❓ Q7. What are the FUNCTIONS of M1 macrophages?

    A:

    M1 macrophages:

    • Produce pro-inflammatory cytokines (IL-1, TNF, IL-6)
    • Generate ROS and NO
    • Promote microbial killing
    • Cause tissue damage

    ➑️ They sustain inflammation.

    ❓ Q8. What activates M2 macrophages?

    A:

    • IL-4
    • IL-13
    • (from Th2 cells)

    ❓ Q9. What are the FUNCTIONS of M2 macrophages?

    A:

    M2 macrophages:

    • Suppress inflammation
    • Promote tissue repair
    • Stimulate fibrosis TGF BETA,FGF
    • Enhance angiogenesis

    ➑️ They drive healing and scarring, not killing.

    ❓ Q10. How do T lymphocytes interact with macrophages in chronic inflammation?

    A:

    Bidirectional loop:

    • Macrophages present antigen β†’ activate T cells
    • T cells secrete cytokines β†’ activate macrophages
    • Creates a self-perpetuating inflammatory cycle

    ❓ Q11. Which T-cell subsets are important in chronic inflammation?

    A:

    • Th1 cells β†’ IFN-Ξ³ β†’ M1 activation
    • Th2 cells β†’ IL-4, IL-13 β†’ M2 activation
    • Th17 cells β†’ IL-17 β†’ neutrophil recruitment

    ❓ Q12. What causes tissue destruction in chronic inflammation?

    A:

    • ROS and NO from macrophages
    • Proteases
    • Persistent cytokine exposure
    • Repeated cycles of injury

    ❓ Q13. Why does fibrosis occur in chronic inflammation?

    A:

    Because:

    • Growth factors (TGF-Ξ², PDGF) are continuously released
    • Fibroblasts are persistently stimulated
    • Collagen deposition exceeds degradation

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    Chronic inflammation is driven by macrophage–T-cell interactions, with M1 macrophages sustaining tissue injury and M2 macrophages promoting repair and fibrosis simultaneously.

    🧠 CLINICAL CORRELATION (High-Yield)

    • TB, sarcoidosis β†’ macrophage-dominant chronic inflammation
    • Rheumatoid arthritis β†’ cytokine-driven synovial destruction
    • Atherosclerosis β†’ chronic inflammation to lipid antigens
    • Anti-TNF therapy targets macrophage cytokine output

    🧠 SARR β€” SEGMENT 10

    TOPIC: GRANULOMATOUS INFLAMMATION β€” STRUCTURE, MECHANISM & EXAM TRAPS

    ❓ Q1. What is granulomatous inflammation?

    A:

    Granulomatous inflammation is a specialized form of chronic inflammation characterized by the formation of granulomas.

    ❓ Q2. What is a granuloma?

    A:

    A granuloma is a compact collection of activated macrophages (epithelioid cells), often surrounded by lymphocytes.

    It forms when the immune system cannot eliminate the offending agent.

    ❓ Q3. Why does the body form granulomas?

    A:

    To:

    • Contain persistent microbes or foreign material
    • Prevent their spread
    • Compensate for failure of elimination

    ➑️ Granuloma = containment strategy.

    ❓ Q4. What cells compose a typical granuloma? (EXAM CORE)

    A:

    • Epithelioid macrophages (activated)
    • Multinucleated giant cells ( Langerhan giant cells)
    • Lymphocytes (mainly T cells)
    • Fibroblasts (late stages)

    ❓ Q5. What are epithelioid cells?

    A:

    Activated macrophages with:

    • Abundant, pink cytoplasm
    • Reduced phagocytic activity
    • Increased secretory function

    They resemble epithelial cells morphologically.

    ❓ Q6. What are multinucleated giant cells?

    A:

    Formed by fusion of macrophages.

    Types:

    • Langhans giant cells β†’ peripheral nuclear arrangement
    • Foreign body giant cells β†’ random nuclear arrangement

    ⚠️ Type of giant cell is not disease-specific.

    ❓ Q7. What immune mechanism drives granuloma formation?

    A:

    A Th1-mediated immune response:

    • Antigen β†’ macrophage presentation
    • T cells β†’ IFN-Ξ³
    • IFN-Ξ³ β†’ macrophage activation
    • Activated macrophages β†’ granuloma formation

    ❓ Q8. What are the MAJOR CAUSES of granulomatous inflammation? (EXAM FAVORITE)

    A:

    1. Infectious
      • Tuberculosis
      • Leprosy
      • Fungal infections
    2. Non-infectious
      • Sarcoidosis
      • Foreign bodies (sutures)
      • Crohn disease
      • Berylliosis

    ❓ Q9. What is caseous necrosis and where is it seen?

    A:

    • A form of necrosis with cheese-like appearance
    • Seen classically in tuberculosis

    ⚠️ Caseation is not present in all granulomas.

    ❓ Q10. What happens to granulomas over time?

    A:

    They may:

    • Persist
    • Heal by fibrosis
    • Cause organ dysfunction due to mass effect or scarring

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    Granulomatous inflammation is a Th1-driven chronic inflammatory response forming granulomas to contain persistent agents that resist eradication.

    🧠 CLINICAL CORRELATION (High-Yield)

    • TB ,Syphyllisβ†’ caseating granulomas
    • Sarcoidosis β†’ non-caseating granulomas
    • Foreign body granulomas β†’ giant cells around inert material
    • Anti-TNF therapy increases risk of TB reactivation

    🧠 SARR β€” SEGMENT 11

    TOPIC: CHEMICAL MEDIATORS OF INFLAMMATION β€” SOURCES, ACTIONS & EXAM TRAPS

    ❓ Q1. What are chemical mediators of inflammation?

    A:

    Chemical mediators are substances that initiate, amplify, and regulate inflammatory reactions.

    They act by:

    • Increasing vascular permeability
    • Causing vasodilation
    • Recruiting and activating leukocytes
    • Inducing tissue damage or repair

    ❓ Q2. What are the TWO major sources of inflammatory mediators? (EXAM CORE)

    A:

    1. Cell-derived mediators
    2. Plasma-derived mediators

    πŸ”Ή CELL-DERIVED MEDIATORS

    ❓ Q3. Which cells produce inflammatory mediators?

    A:

    • Mast cells
    • Macrophages
    • Neutrophils
    • Endothelial cells
    • Platelets

    ❓ Q4. What is the MOST IMPORTANT preformed cell-derived mediator?

    A:

    Histamine

    ❓ Q5. What are the actions of histamine? (EXAM FAVORITE)

    A:

    Histamine causes:

    • Vasodilation
    • Increased vascular permeability (endothelial contraction)

    Released from:

    • Mast cells (major source)
    • Basophils
    • Platelets

    ❓ Q6. What triggers histamine release?

    A:

    • Physical injury
    • Immune reactions (IgE-mediated)
    • Complement components (C3a, C5a)
    • Neuropeptides

    ❓ Q7. What are arachidonic acid metabolites?

    A:

    Lipid mediators derived from cell membrane phospholipids via:

    • Cyclooxygenase (COX)
    • Lipoxygenase (LOX) pathways

    ❓ Q8. What are the MAJOR prostaglandins and their actions?

    image

    A:

    • PGIβ‚‚ (prostacyclin) β†’ vasodilation, inhibits platelet aggregation
    • PGEβ‚‚ β†’ pain, fever, vasodilation, permiability
    • PGDβ‚‚ β†’ vasodilation, permeability

    ❓ Q9. What are leukotrienes and their effects? (EXAM CORE)

    A:

    • LTBβ‚„ β†’ powerful neutrophil chemotaxis
    • LTCβ‚„, LTDβ‚„, LTEβ‚„ β†’ vasoconstriction, bronchospasm, ↑ permeability

    ❓ Q10. What are lipoxins?

    A:

    Lipoxins are anti-inflammatory arachidonic acid derivatives that:

    • Inhibit neutrophil recruitment
    • Promote resolution
    • lipoxin A4,B4

    ❓ Q11. What are cytokines?

    A:

    Low-molecular-weight proteins that coordinate inflammatory responses.

    ❓ Q12. Which cytokines are MOST important in inflammation? (EXAM FAVORITE)

    A:

    • TNF
    • IL-1
    • IL-6

    ❓ Q13. What are the major actions of TNF and IL-1?

    A:

    They cause:

    • Endothelial activation
    • Leukocyte recruitment
    • Fever
    • Acute-phase protein synthesis
    • Cachexia (TNF)

    ❓ Q14. What are chemokines?

    A:

    A subset of cytokines that:

    • Direct leukocyte chemotaxis
    • Regulate leukocyte trafficking

    Example:

    • IL-8 β†’ neutrophil chemotaxis(CXC)

    ❓ Q15. What is nitric oxide (NO) and its role?

    A:

    NO causes:

    • Vasodilation
    • Microbial killing
    • Inhibition of platelet aggregation

    Produced by:

    • Endothelium
    • Macrophages

    ❓ Q16. What are reactive oxygen species (ROS)?

    A:

    Short-lived oxygen radicals that:

    • Kill microbes
    • Cause host tissue damage when excessive

    πŸ”Ή PLASMA-DERIVED MEDIATORS

    ❓ Q17. Which plasma protein systems generate inflammatory mediators?

    A:

    1. Complement system
    2. Kinin system
    3. Coagulation system
    4. Fibrinolytic system

    ❓ Q18. What are the IMPORTANT complement components and actions? (EXAM CORE)

    A:

    • C3a, C5a β†’ anaphylatoxins (vasodilation, permeability)
    • C5a β†’ chemotaxis, leukocyte activation
    • C3b β†’ opsonization
    • MAC (C5b-9) β†’ microbial lysis

    ❓ Q19. What is bradykinin and its actions?

    A:

    Bradykinin causes:

    • Vasodilation
    • Increased permeability
    • Pain

    ❓ Q20. What is the KEY RULE about inflammatory mediators? (EXAM TRAP)

    A:

    Most mediators:

    • Have short half-lives
    • Act locally
    • Are tightly regulated

    Uncontrolled release β†’ tissue damage.

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    Inflammatory mediators are short-lived cell- and plasma-derived molecules that regulate vascular changes, leukocyte recruitment, tissue injury, and resolution.

    🧠 CLINICAL CORRELATION (High-Yield)

    • NSAIDs β†’ inhibit COX β†’ ↓ prostaglandins
    • Steroids β†’ block phospholipase Aβ‚‚ β†’ ↓ all arachidonic acid mediators
    • Anti-TNF therapy β†’ suppresses chronic inflammatory diseases

    🧠 SARR β€” SEGMENT 12

    TOPIC: PATTERNS OF ACUTE INFLAMMATION β€” MORPHOLOGY, MECHANISM & EXAM TRAPS

    Q1. What are β€œpatterns” of acute inflammation?

    A:

    They are morphologic expressions of acute inflammation determined by:

    • Severity of injury
    • Type of tissue involved
    • Nature of the inflammatory exudate

    ❓ Q2. What are the MAIN patterns of acute inflammation? (EXAM CORE)

    A:

    1. Serous inflammation
    2. Fibrinous inflammation
    3. Suppurative (purulent) inflammation
    4. Ulcerative inflammation

    πŸ”Ή 1. SEROUS INFLAMMATION

    ❓ Q3. What is serous inflammation?

    A:

    An acute inflammation characterized by thin, watery, cell-poor exudate derived from plasma or mesothelial secretions.

    ❓ Q4. Where is serous inflammation commonly seen?

    A:

    • Skin (e.g. burn blister)
    • Serous cavities:
      • Pleura
      • Peritoneum
      • Pericardium

    ❓ Q5. What is the mechanism of serous inflammation?

    A:

    • Mild increase in vascular permeability
    • Minimal leukocyte involvement

    πŸ”Ή 2. FIBRINOUS INFLAMMATION

    ❓ Q6. What is fibrinous inflammation?

    A:

    Inflammation with large amounts of fibrin in the exudate due to severe vascular permeability.

    ❓ Q7. Where is fibrinous inflammation typically seen?

    A:

    • Serosal surfaces:
      • Pericardium
      • Pleura
      • Peritoneum

    Classic example:

    • Fibrinous pericarditis (β€œbread and butter” appearance)

    ❓ Q8. What happens to fibrin in fibrinous inflammation?

    A:

    Two possibilities:

    1. Fibrinolysis β†’ resolution
    2. Organization β†’ fibrosis and adhesions

    πŸ”Ή 3. SUPPURATIVE (PURULENT) INFLAMMATION

    ❓ Q9. What is suppurative inflammation?

    A:

    Inflammation characterized by production of pus, consisting of:

    • Neutrophils
    • Necrotic cells
    • Edema fluid

    ❓ Q10. What organisms commonly cause suppuration?

    A:

    Pyogenic bacteria

    (e.g. Staphylococcus)

    ❓ Q11. What is an abscess? (EXAM FAVORITE)

    A:

    A localized collection of pus within tissue, organ, or confined space.

    ❓ Q12. What is the fate of an abscess?

    A:

    • necrotic tissue debris in middle, neutrophils around it
    • Surrounded by a fibrous wall
    • Often requires surgical drainage
    • Heals by fibrosis

    πŸ”Ή 4. ULCERATIVE INFLAMMATION

    ❓ Q13. What is an ulcer?

    A:

    A local defect or excavation of the surface of an organ or tissue produced by sloughing of necrotic tissue.

    ❓ Q14. Where are ulcers commonly found?

    A:

    • Gastrointestinal tract
      • Peptic ulcers
    • Skin
      • Pressure sores
    • Oral cavity
    • acute stage there is intense polymorphonuclear infiltration and vascular dilation in the margins of the defect.
    • chronicity, the margins and base of the ulcer develop fibroblast proliferation, scarring, and the accumulation of lymphocytes, macrophages, and plasma cells.

    ❓ Q15. Why is ulceration important clinically?

    A:

    Because ulcers:

    • May bleed
    • May perforate
    • Heal with scarring
    • Can become chronic

    πŸ”‘ EXAM LOCK β€” PATTERN MEMORY

    • Serous β†’ watery, cell-poor
    • Fibrinous β†’ fibrin-rich, severe permeability
    • Suppurative β†’ pus, neutrophils
    • Ulcer β†’ surface necrosis and sloughing

    🧠 CLINICAL CORRELATION (High-Yield)

    • Burn blister β†’ serous inflammation
    • Fibrinous pericarditis β†’ friction rub
    • Abscess β†’ needs drainage, antibiotics alone insufficient
    • Chronic ulcer β†’ fibrosis, scarring

    🧠 SARR β€” SEGMENT 13

    TOPIC: TISSUE REPAIR AFTER INFLAMMATION β€” REGENERATION vs SCARRING

    ❓ Q1. What happens to tissues after inflammation subsides?

    A:

    Tissues undergo repair, which occurs by:

    1. Regeneration
    2. Scarring (fibrosis)

    Sometimes both occur together.

    ❓ Q2. What is regeneration?

    A:

    Regeneration is the replacement of injured tissue by the same type of cells, resulting in restoration of normal structure and function.

    ❓ Q3. Which tissues can regenerate? (EXAM CORE)

    A:

    • Labile tissues
      • Epithelia (skin, GI mucosa)
      • Hematopoietic cells
    • Stable tissues (if framework intact) Arrest at G0
      • Liver
      • Kidney
      • Endothelium

    ❓ Q4. What conditions are REQUIRED for regeneration?

    A:

    • Intact basement membrane
    • Viable stem cells
    • Minimal damage to connective tissue framework

    ❓ Q5. What is scarring (fibrosis)?

    A:

    Replacement of injured tissue by connective tissue (collagen) rather than parenchymal cells.

    Results in:

    • Structural support
    • Loss of original function

    ❓ Q6. When does scarring occur? (EXAM FAVORITE)

    A:

    • Extensive tissue destruction
    • Damage to connective tissue framework
    • Injury to permanent cells
      • Neurons
      • Cardiac myocytes

    ❓ Q7. What are the KEY STEPS in scar formation?

    A:

    1. Angiogenesis
    2. Fibroblast migration & proliferation
    3. Collagen deposition
    4. Tissue remodeling

    ❓ Q8. What role does inflammation play in repair?

    A:

    Inflammation:

    • Clears necrotic tissue
    • Provides growth factors
    • Initiates repair

    But prolonged inflammation:

    • Impairs regeneration
    • Promotes fibrosis

    ❓ Q9. What determines regeneration vs scarring? (DECISION LOGIC)

    A:

    • Tissue type
    • Severity of injury
    • Integrity of extracellular matrix
    • Duration of inflammation

    ❓ Q10. Can regeneration and scarring occur together?

    A:

    Yes.

    Example:

    • Skin wounds β†’ epithelial regeneration + dermal scar

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    After inflammation, tissues heal by regeneration if the framework is intact, or by scarring when damage is extensive or permanent cells are injured.

    🧠 CLINICAL CORRELATION (High-Yield)

    • Myocardial infarction β†’ scarring, no regeneration
    • Liver injury β†’ regeneration if framework intact
    • Chronic inflammation β†’ fibrosis and organ dysfunction

    14 TOPIC: FACTORS AFFECTING INFLAMMATION & TISSUE REPAIR β€” SYSTEMIC + LOCAL

    ❓ Q1. Why do some wounds heal well while others do not?

    A:

    Because inflammation and repair are influenced by local and systemic factors that can enhance or impair healing.

    ❓ Q2. What are the TWO broad categories of factors affecting repair? (EXAM CORE)

    A:

    1. Local factors
    2. Systemic factors

    πŸ”Ή LOCAL FACTORS

    ❓ Q3. How does infection affect tissue repair?

    A:

    • Most important local cause of delayed healing
    • Prolongs inflammation
    • Increases tissue injury
    • Interferes with repair processes

    ❓ Q4. How does poor blood supply affect repair?

    A:

    • Reduces oxygen delivery
    • Impairs leukocyte function
    • Decreases fibroblast activity

    Example:

    • Ischemic limbs heal poorly

    ❓ Q5. How do foreign bodies affect repair?

    A:

    • Sustain inflammation
    • Prevent wound closure
    • Increase risk of infection

    ❓ Q6. How does mechanical stress affect repair?

    A:

    • Excess movement disrupts healing tissue
    • Can cause wound dehiscence

    ❓ Q7. How does wound size and type affect healing?

    A:

    • Larger wounds β†’ more scarring
    • Wounds in highly vascular tissues heal faster

    πŸ”Ή SYSTEMIC FACTORS

    ❓ Q8. How does nutritional status affect repair? (EXAM FAVORITE)

    A:

    • Protein deficiency β†’ ↓ collagen synthesis
    • Vitamin C deficiency β†’ impaired collagen cross-linking
    • Zinc deficiency β†’ delayed epithelialization

    ❓ Q9. How does diabetes mellitus impair wound healing?

    A:

    • Microvascular disease β†’ poor perfusion
    • Impaired leukocyte function
    • Increased susceptibility to infection

    ❓ Q10. How do glucocorticoids affect repair?

    A:

    • Suppress inflammation
    • Inhibit fibroblast proliferation
    • Decrease collagen synthesis

    ❓ Q11. How does age affect tissue repair?

    A:

    • Elderly β†’ slower healing
    • Reduced cell proliferation
    • Decreased angiogenesis

    ❓ Q12. How do systemic illnesses affect repair?

    A:

    • Chronic diseases impair healing
    • Examples:
      • Anemia
      • Renal failure

    πŸ”‘ EXAM LOCK β€” HIGH-YIELD LIST

    • Infection β†’ most important cause of delayed healing
    • Poor perfusion β†’ ischemia = poor repair
    • Diabetes + steroids β†’ impaired inflammation and repair
    • Protein & vitamin C β†’ essential for collagen

    🧠 CLINICAL CORRELATION (High-Yield)

    • Diabetic foot ulcers β†’ impaired healing + infection
    • Steroid-treated patients β†’ delayed wound repair
    • Pressure sores β†’ ischemia + necrosis

    🧠 SARR β€” ADD-ON SEGMENT: ANGIOGENESIS (New Vessel Formation)

    TOPIC: ANGIOGENESIS β€” DEFINITION, STEPS, MEDIATORS, CLINICAL

    ❓ Q1. What is angiogenesis?

    A:

    Angiogenesis is the formation of new blood vessels from pre-existing vessels, mainly via endothelial cell sprouting.

    ❓ Q2. Why is angiogenesis important in pathology and healing?

    A:

    It is required for:

    • Wound healing (granulation tissue)
    • Repair after inflammation
    • Tumor growth (tumors need new vessels)
    • Collateral formation in ischemia

    ❓ Q3. What are the major steps of angiogenesis? (EXAM SEQUENCE)

    A:

    1. Vasodilation and increased permeability
    2. Pericyte detachment from the vessel wall
    3. Basement membrane degradation
    4. Endothelial cell migration toward the angiogenic stimulus
    5. Endothelial cell proliferation
    6. Tube (lumen) formation
    7. Recruitment of periendothelial support cells
      • Pericytes (capillaries)
      • Smooth muscle cells (larger vessels)
    8. Basement membrane deposition and maturation
    9. Suppression of endothelial proliferation (stabilization)

    ❓ Q4. What mediates vasodilation in angiogenesis?

    A:

    Nitric oxide (NO) is a key mediator of vasodilation.

    ❓ Q5. What is the most important growth factor for angiogenesis?

    A:

    VEGF (vascular endothelial growth factor)

    ❓ Q6. What are the key actions of VEGF?

    A:

    VEGF causes:

    • Endothelial cell proliferation
    • Endothelial cell migration
    • Vasodilation (via NO)
    • Increased vascular permeability (very important early step)

    ❓ Q7. Which other growth factor is important in angiogenesis and why?

    A:

    FGF-2 (fibroblast growth factor-2) promotes:

    • Endothelial proliferation
    • Migration
    • Vessel formation

    ❓ Q8. What breaks down the basement membrane to allow sprouting?

    A:

    Proteases, especially matrix metalloproteinases (MMPs), degrade:

    • Basement membrane
    • Extracellular matrix
    • This creates a pathway for endothelial migration.

    ❓ Q9. What is granulation tissue and why is it called that?

    A:

    Granulation tissue is the healing tissue composed of:

    • Newly formed capillaries (angiogenesis)
    • Proliferating fibroblasts
    • Loose extracellular matrix
    • Inflammatory cells (variable)

    It looks β€œgranular” because of many small new vessels.

    ❓ Q10. How do new vessels become stable and mature?

    A:

    They stabilize by:

    • Recruitment of pericytes/smooth muscle
    • Basement membrane deposition
    • Reduced endothelial proliferation and permeability

    πŸ”‘ EXAM LOCK β€” ONE-LINE RECALL

    Angiogenesis is VEGF-driven sprouting of new vessels from existing ones via endothelial migration, proliferation, tube formation, and maturation with pericyte recruitment and basement membrane deposition.

    🧠 CLINICAL CORRELATION (Concise)

    • Tumors promote angiogenesis mainly through VEGF β†’ allows growth and metastasis
    • Anti-VEGF therapy can slow tumor vascular supply
    • Diabetes/poor perfusion impairs angiogenesis β†’ delayed wound healing
    • Granulation tissue = angiogenesis + fibroblasts + loose ECM

    🧠 SARR β€” SEGMENT 16

    TOPIC: FIBROBLAST ACTIVATION, COLLAGEN SYNTHESIS & ECM DEPOSITION

    ❓ Q1. What is the central cell in scar formation?

    A:

    The fibroblast.

    It produces:

    • Collagen
    • Extracellular matrix (ECM) proteins

    ❓ Q2. What activates fibroblasts during tissue repair? (EXAM CORE)

    A:

    Growth factors released from:

    • Macrophages
    • Platelets
    • Endothelial cells

    Key mediators:

    • TGF-Ξ² (most important)
    • PDGF
    • FGF
    • IL-13

    ❓ Q3. What is the role of TGF-Ξ² in repair?

    A:

    TGF-Ξ²:

    • Stimulates fibroblast proliferation
    • Increases collagen synthesis
    • Decreases ECM degradation
    • Promotes fibrosis

    ➑️ Central mediator of scarring.

    ❓ Q4. Which type of collagen is deposited first in wounds?

    A:

    Type III collagen (early, provisional).

    Later replaced by Type I collagen.

    ❓ Q5. What other ECM components are deposited besides collagen?

    A:

    • Fibronectin
    • Proteoglycans
    • Hyaluronic acid
    • Elastin (later)

    ❓ Q6. What balances ECM synthesis and degradation?

    A:

    • Matrix metalloproteinases (MMPs) β†’ degrade ECM
    • TIMPs (tissue inhibitors of metalloproteinases) β†’ inhibit MMPs

    πŸ”‘ EXAM LOCK β€” ONE LINE

    Fibroblast activation driven by TGF-Ξ² leads to collagen (III β†’ I) and ECM deposition, forming the structural basis of scar tissue.

    🧠 SARR β€” SEGMENT 17

    TOPIC: WOUND HEALING β€” PRIMARY vs SECONDARY INTENTION

    ❓ Q1. What is healing by primary intention?

    A:

    Healing of clean, uninfected wounds with closely approximated edges.

    Example:

    • Surgical incision

    ❓ Q2. What are the features of primary intention healing?

    A:

    • Minimal tissue loss
    • Minimal inflammation
    • Minimal granulation tissue
    • Small scar

    ❓ Q3. What is healing by secondary intention?

    A:

    Healing of wounds with:

    • Extensive tissue loss
    • Widely separated edges

    Example:

    • Large ulcers
    • Abscess cavities

    ❓ Q4. What are the features of secondary intention healing?

    A:

    • More inflammation
    • Abundant granulation tissue
    • Wound contraction
    • Large scar

    ❓ Q5. What causes wound contraction? (EXAM FAVORITE)

    A:

    Myofibroblasts:

    • Fibroblasts with smooth muscle–like features
    • Pull wound edges together

    πŸ”‘ EXAM LOCK β€” COMPARISON

    • Primary intention β†’ small wound, small scar
    • Secondary intention β†’ large wound, contraction, large scar

    🧠 SARR β€” SEGMENT 18

    TOPIC: COMPLICATIONS OF WOUND HEALING (EXAM FAVORITES)

    ❓ Q1. What are the main categories of wound healing complications?

    A:

    1. Deficient scar formation
    2. Excessive scar formation
    3. Contractures

    πŸ”Ή DEFICIENT HEALING

    ❓ Q2. What causes wound dehiscence?

    A:

    • Inadequate collagen synthesis
    • Increased wound stress
    • Infection
    • Poor perfusion

    ➑️ Leads to wound reopening.

    ❓ Q3. What causes chronic ulceration?

    A:

    • Poor vascular supply
    • Diabetes
    • Persistent pressure

    πŸ”Ή EXCESSIVE HEALING

    ❓ Q4. What is a hypertrophic scar?

    A:

    • Excess collagen deposition
    • Scar remains within wound boundaries
    • Often regresses with time

    ❓ Q5. What is a keloid? (VERY HIGH-YIELD)

    A:

    • Excessive collagen deposition
    • Scar extends beyond wound margins
    • Does not regress
    • More common in:
      • Dark-skinned individuals
      • Earlobes, shoulders, sternum

    ❓ Q6. What is the collagen composition of keloids?

    A:

    • Increased Type III collagen
    • Excess growth factor signaling (TGF-Ξ²)

    πŸ”Ή CONTRACTURES

    ❓ Q7. What are contractures and where are they seen?

    A:

    • Exaggerated wound contraction
    • Common after:
      • Burns
      • Palmar/plantar wounds

    ➑️ Cause restricted movement.

    πŸ”‘ FINAL EXAM LOCK

    Abnormal wound healing results from imbalance between collagen synthesis, degradation, and contraction, leading to dehiscence, hypertrophic scars, keloids, or contractures.